|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical relevance of urokinase-type plasminogen activator,its receptor,and its inhibitor type I in endometrial cancer显示文摘 | Tecimer C Doering DL Goldsmith LJ | 2001 | Gynecol Oncol2001，80，1： | 1 |
| 2 | Metastatic dermatofibrosarcoma protuberans of the vulva显示文摘 | Soergel TM Doering DL O'Connor D | 1998 | Gynecol Oncol1998，71，： | 1 |
| 3 | Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's显示文摘 | Meissner KK Kirkham DL Doering LC | 2005 | Brain Res2005，1057，12： | 1 |
| 4 | Clinical relevance of urokinase-type plasminogen activator, its receptor, and its inhibitor type 1 in endome-trial cancer显示文摘 | Tecimer C Doering DL Goldsmith LJ | 2001 | Gynecol Oncol2001，80，1： | 1 |
| 5 | Clinical relevance of urokinase-type plasminogen activator,its receptor and inhibitor type 1 in ovarian cancer显示文摘 | Tecimer C Doering DL Goldsmith LJ | 2000 | Int J Gynecol Cancer2000，10，5： | 1 |
| 6 | Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer 显示文摘 | Tecimer C Doering DL Goldsmith LJ Meyer JS Abdulhay G Wittliff JL | 2000 | Int J Gynccol Cancer2000，10，5： | 1 |
| 7 | Clinical relevance of urokinase - type plasminogen activator,its receptor and inhibitor type 1 in ovarian cancer 显示文摘 | Tecimer C Doering DL Goldsmith LJ | 2000 | Int J Gynecol Cancer2000，10，5： | 1 |
| 8 | Chnical relevance of urokinase-type plasminogen activator, its receptor and inhibitor typel in ovarianc ancer显示文摘 | Tecimer C Doering DL Goldsmith LJ | 2000 | Int J Gynecol Cancer2000，10，5： | 1 |
| 9 | Transplants of neurosphere cell suspensions from aged mice are functional in the mouse model of Parkinson's显示文摘 | Meissner KK Kirkham DL Doering LC | 2005 | Brain Res2005，1057，12： | 1 |
| 10 | Clinical relevance of urokinase - type plasminogan activator, its receptor, and its inhibitor type 1 in endometrial cancer 显示文摘 | Tecimer C Doering DL Goldsmith LJ | 2001 | Gynecal Oncol2001，80，1： | 1 |
| 11 | Clinical relevance of urokinase-type plasminogen activator,its receptor,and its inhibitor type 1 in endometrial cancer显示文摘 | Tecimer C Doering DL Goldsmith LJ | 2001 | Gynecol Oncol2001，80，1： | 1 |
| 12 | Skin test anergy in advanced chronic heart failure secondary to either ischemic or idiopathic dilated car- diomyopathy 显示文摘 | Vredevoe DL Woo MA Doering LV | 1998 | Am J Cardiol1998，82，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员